NCT06310850View on ClinicalTrials.gov

The Effect of Preprocedural Subanesthetic Ketamine on Pain and Anxiety

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

January 1, 2023

Study Completion Date

June 1, 2023

Conditions
Epidural CatheterizationThoracicProcedural Pain
Interventions
DRUG

Ketamine

Patients will be administered 0.15 mg kg-1 intravenous ketamine (The sample provided contains equal proportions of two enantiomers, S and R ketamine hydrochloride.) 3 minutes before thoracic epidural catheter placement.

OTHER

Placebo

Intravenous saline will be administered to patients 3 minutes before the thoracic epidural catheter is placed.

Trial Locations (1)

06290

Ankara Atatürk Sanatorium Training and Research Hospital, Ankara

All Listed Sponsors
lead

Ankara Ataturk Sanatorium Training and Research Hospital

OTHER_GOV

NCT06310850 - The Effect of Preprocedural Subanesthetic Ketamine on Pain and Anxiety | Biotech Hunter | Biotech Hunter